(NAFLD) (DBCOND0039962)

Identifiers

Synonyms
NAFLD / Non-alcoholic fatty liver disease (disorder) / Non-alcoholic fatty liver / Fatty (change of) liver, not elsewhere classified / Nonalcoholic fatty liver disease / Non-alcoholic fatty liver (disorder) / Non-alcoholic Fatty Liver Disease

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05521633
Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Livertreatment3completed
NCT02933554
Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04302051
Assessment of Fatty Liver With Thermo-acoustic DeviceNo drug interventionsNot AvailableNot Availablerecruiting
NCT03913351
Lifestyle Modification Programme for HIV-infected Individuals With Fatty LiverNo drug interventionstreatmentNot Availablerecruiting
NCT06038253
Relation Between NAFLD and BM DENSITYNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05128253
Characterization of the Platelet Inflammatory Response in NAFL and NASHNo drug interventionsNot AvailableNot Availableunknown_status
NCT05370053
The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to HepatologyNo drug interventionsscreeningNot Availableunknown_status
NCT05669677
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06332677
Target of Suv420h1/2 in HepatocytesNo drug interventionspreventionNot Availablerecruiting
NCT06047847
Determination of Biological Activity of Enriched Serum Following TOTUM-448 ConsumptionNo drug interventionsbasic_scienceNot Availablecompleted
NCT05877547
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)treatment2active_not_recruiting
NCT02948647
Healthy Eating Through Reduction Of Excess SugarNo drug interventionstreatmentNot Availablecompleted
NCT03090347
Effects of Dietary Nutrients on Liver and Adipose Tissue MetabolismNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05984745
Effect of CoQ10 on the Outcome of MAFLD Patientstreatment2recruiting
NCT05217745
MLCT Oil for Fatty Liver - PASS TrialNo drug interventionstreatmentNot Availableunknown_status
NCT03587298
Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availableunknown_status
NCT06315361
DIAbetes and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06124261
Androgens and NAFLD Longitudinal Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06445361
Prevalence of NAFLD in T1DM PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02358928
Low Carbohydrate Diet: The Effects on Non Alcoholic Fatty Liver Disease in Obese Teens With Metabolic SyndromeNo drug interventionstreatmentNot Availablecompleted
NCT04982328
COVID-19 and Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04232293
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes MellitusNo drug interventionsdiagnosticNot Availablerecruiting
NCT05402371
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosistreatment2active_not_recruiting
NCT04861571
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLDNo drug interventionstreatment1recruiting
NCT05359471
Characterization of Visceral Adiposity in HIV Mono-infected Patients With NAFLDNo drug interventionshealth_services_researchNot Availableunknown_status
NCT03528707
Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT04073407
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionsbasic_scienceNot Availableterminated
NCT05560607
Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsother1completed
NCT05480007
Non-alcoholic Fatty Liver Disease and Its TreatmenttreatmentNot Availablecompleted
NCT02546609
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Diseasetreatment2completed
NCT06124456
Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT02964715
The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetestreatment4unknown_status
NCT05816915
Lifestyle Modification in the Treatment of NAFLD.No drug interventionstreatmentNot Availablerecruiting
NCT05108415
Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis TestNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05647915
Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLDtreatment4not_yet_recruiting
NCT05052515
The Effects of Natural Extracts Supplementation on NASH PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT05844137
Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 DiabetesNo drug interventionstreatmentNot Availablecompleted
NCT06357052
The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availablecompleted
NCT02083159
C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05463575
Ketohexokinase Inhibition in NAFLDNo drug interventionstreatment2completed
NCT01355575
Rifaximin in Fatty Liver Diseasetreatment4terminated
NCT01913470
Study of Losartan in the Treatment of NAFLD in Childrentreatment2completed
NCT04127370
The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT02952170
Impact of Weight Loss Surgery in Adolescents With NAFLDNo drug interventionspreventionNot Availablecompleted
NCT05305599
Different Doses of ZED1227 vs. Placebo in NAFLDtreatment2completed
NCT05092399
Effects of VLCD and Bariatric Surgery in Patients With Type 2 DiabetesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04591106
Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRENo drug interventionsNot AvailableNot Availablerecruiting
NCT03291249
Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DMtreatment2withdrawn
NCT01798719
Effect of Mediterranean Diet on Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT04795219
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIVNo drug interventionsNot AvailableNot Availablerecruiting
NCT02098317
DHA and Vitamin D in Children With Biopsy-proven NAFLDtreatment3completed
NCT06098417
Biomarkers in the Diagnosis and Prognosis of NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT04442334
The European NAFLD RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05768334
Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Diseasetreatment3completed
NCT05554224
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04783116
Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenNo drug interventionstreatmentNot Availableunknown_status
NCT05986916
Accurate Point of Care Liver Disease DiagnosticsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03380416
Effects of a Portfolio Diet on NAFLD in Type 2 Diabetic PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02459496
Diabetes Nutrition Algorithms in Patients With Overt Diabetes MellitusNo drug interventionstreatmentNot Availableunknown_status
NCT03695796
French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)No drug interventionsdiagnosticNot Availablerecruiting
NCT05960396
Exploring the Mechanism of Dietary Pattern Improving MAFLDNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02347696
Diet and Physical Activity on NAFLD and Erytrocyte Membrane Lipid Profile.No drug interventionstreatmentNot Availableunknown_status
NCT04248335
Effect of Obesity on Proton Pump Inhibitorstreatment4recruiting
NCT04704063
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)treatment2completed
NCT04834063
Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02122263
Transient Elastography of the Liver ( Fibroscan ) and Bariatric SurgeryNo drug interventionsNot AvailableNot Availableunknown_status
NCT05699863
The MULTISITE StudyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06348563
AGED Diagnostics Liver Disease AssessmentNo drug interventionsdiagnostic0not_yet_recruiting
NCT04997486
The Effect of Time-restricted Eating on Liver MetabolismNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06060886
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysistreatment4not_yet_recruiting
NCT02458586
Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)No drug interventionstreatmentNot Availableunknown_status
NCT04187339
Study of NGM395 in Adult ParticipantsNo drug interventionstreatment1completed
NCT03261739
Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)treatment1completed
NCT04692025
Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy VolunteersNo drug interventionstreatment1completed
NCT04084925
HOMA-IR as a Screening Test in NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT02558530
Resolution of Liver Fat in Non-alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT01922830
Probiotics and Microbiota in Bariatric SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT06308757
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With FibrosisNo drug interventionstreatmentNot Availablerecruiting
NCT05935826
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)treatment3recruiting
NCT06334666
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03844165
Fighting Fatty Liver in IndiaNo drug interventionsotherNot Availableunknown_status
NCT05971082
Risk Factors for Advanced Fibrosis Among FLD PatientsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04193982
An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)treatment3unknown_status
NCT03365531
RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver DiseaseNo drug interventionstreatmentNot Availableterminated
NCT04681573
Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLDNo drug interventionsdiagnosticNot Availableunknown_status
NCT03726827
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsNo drug interventionsNot AvailableNot Availablecompleted
NCT03674476
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Functiontreatment1completed
NCT04186260
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American MenNo drug interventionstreatmentNot Availablerecruiting
NCT06386094
Cardiac Dysfunction in Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06074094
Probiotic Supplementation IN NAFLD PatientsNo drug interventionstreatment4completed
NCT04686994
Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese SubjectsNo drug interventionstreatment1completed
NCT02647294
Polyunsaturated Fatty Acids in Patients With NAFLD.No drug interventionstreatmentNot Availablecompleted
NCT04564391
Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow ProteinsNo drug interventionstreatmentNot Availablerecruiting
NCT06354491
An Imaging-based Quantitative Biomarker Assay for NAFLD in ChildrenNo drug interventionsNot AvailableNot Availablerecruiting
NCT04812262
A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLDNo drug interventionstreatment1completed
NCT02132780
Autonomic Dysfunction in Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT03919929
Treating PCOS With Semaglutide vs Active Lifestyle Interventiontreatment2 / 3active_not_recruiting
NCT04756544
The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation and Oxidative Stress Parameters and Faecal Microbiota in Patients With Depression Depending on Metabolic Syndrome ComorbidityNo drug interventionstreatment3unknown_status
NCT03656744
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)No drug interventionstreatment2completed
NCT05023044
Nonalcoholic Fatty Liver Disease in HIV DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02133144
Effects of Overfeeding Followed by Weight Loss on Liver Fat Content and Adipose Tissue InflammationNo drug interventionspreventionNot Availableunknown_status
NCT05195944
Semaglutide vs Sitagliptintreatment4enrolling_by_invitation
NCT05813301
NAFLD in Patient of HypothyroidismNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03391401
Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05168072
Weight Loss Effects of M-health App in Obesity Multidisciplinary Outpatient ClinicNo drug interventionstreatmentNot Availableunknown_status
NCT06503068
Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05781568
Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)No drug interventionsNot AvailableNot Availablerecruiting
NCT04073368
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionsbasic_scienceNot Availablecompleted
NCT06186869
Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT05872269
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbiditiestreatment4recruiting
NCT06413069
Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)No drug interventionstreatmentNot Availablerecruiting
NCT03118310
Treatment of NAFLD With Two Different DietsNo drug interventionstreatment2completed
NCT03864510
NAFLD in Diabetes Type 2 in Primary CareNo drug interventionsNot AvailableNot Availablecompleted
NCT01807910
ER Stress in NAFLDbasic_science0withdrawn
NCT06220695
A Nutrigenetic Intervention in MASLDNo drug interventionspreventionNot Availableactive_not_recruiting
NCT02193295
Reversal of Lipid-Induced Insulin ResistanceNo drug interventionsbasic_scienceNot Availablerecruiting
NCT04321395
Vigabatrin and Insulin Sensitivityother2completed
NCT03047655
Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic SyndromeNo drug interventionspreventionNot Availableunknown_status
NCT05843955
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT05884723
Preoperative Ketogenic Diet for Reduction of Hepatic SteatosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03534908
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05527938
Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese ChildrenNo drug interventionssupportive_careNot Availablecompleted
NCT04895943
Bariatric Endoscopy and NAFLDNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05147090
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis Btreatment4recruiting
NCT06563921
RE and Probiotics in MAFLD/NAFLDNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04581421
The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid ContentNo drug interventionsbasic_scienceNot Availablecompleted
NCT05720702
A Feasibility Trial of OCM Supplements for the Treatment of NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT05364684
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Diseasetreatment2recruiting
NCT02927184
Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Diseasetreatment2completed
NCT06229184
Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?No drug interventionsscreeningNot Availablecompleted
NCT03512184
YMCA Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)No drug interventionshealth_services_researchNot Availablecompleted
NCT06176079
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver DiseaseNot AvailableNot Availablerecruiting
NCT04987879
NASH AMPK Exercise Dosing (AMPED) TrialNo drug interventionstreatmentNot Availablerecruiting
NCT05784779
Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLDNo drug interventionstreatment1 / 2recruiting
NCT03867487
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Diseasetreatment2not_yet_recruiting
NCT03669133
Vitamin E for NASH Treatment in HIV Infected Individualstreatment2terminated
NCT06101433
The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin ANo drug interventionstreatmentNot Availablecompleted
NCT03968354
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)No drug interventionsNot AvailableNot Availableunknown_status
NCT06389851
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLDNo drug interventionstreatmentNot Availablerecruiting
NCT02654977
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophytreatment2completed
NCT04292977
Splanchnic and Systemic VLDL-TG and FFA BalanceNo drug interventionsNot AvailableNot Availablecompleted
NCT02764047
Probiotics in the Treatment of NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT05607745
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB StudyNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT04006145
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASHtreatment2completed
NCT06566105
The Liver BIoBank Lombardia of Fatty LiverNo drug interventionspreventionNot Availablerecruiting
NCT05654805
Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT04779905
Chronic Kidney Disease and Non-alcoholic Fatty Liver DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT03289897
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScanNo drug interventionsotherNot Availablecompleted
NCT05184283
Utilization of MAsS in Patients Undergoing LT for HCCNo drug interventionsNot AvailableNot Availableterminated
NCT04976283
Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Livertreatment4unknown_status
NCT05773183
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNot AvailableNot Availablenot_yet_recruiting
NCT05576428
Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLDtreatmentNot Availablenot_yet_recruiting
NCT05930093
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD SubjectsNo drug interventionstreatmentNot Availablerecruiting
NCT04081571
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among EgyptianNo drug interventionsNot AvailableNot Availableunknown_status
NCT06396871
Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03233178
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04910178
Follow-up of NAFLD Patients With MRI-PDFFtreatment4completed
NCT05506488
Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Diseasetreatment1 / 2recruiting
NCT05383456
The Visceral Adiposity Measurement and Observation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT06257732
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on MyokinesNo drug interventionstreatmentNot Availablerecruiting
NCT04465032
The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)No drug interventionstreatment4unknown_status
NCT02216552
Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight AdolescentsNo drug interventionsprevention2 / 3completed
NCT01281059
Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath TestNo drug interventionsNot AvailableNot Availableunknown_status
NCT06111859
Effectiveness of Ultrasound in Liver Stiffness and Fat QuantificationNo drug interventionsdiagnosticNot Availablerecruiting
NCT04669470
Bariatric Endoscopy and NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT05140070
Fruit and Vegetable Products Enriched With Fibre From Potato Starch With Prebiotic Properties for Children and YouthNo drug interventionstreatmentNot Availableunknown_status
NCT02367742
Effect of Physical Activity on NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT02726542
Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescentstreatment0completed
NCT02051842
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosistreatment4unknown_status
NCT04366999
Effectiveness of Bariatric Surgery for NAFLD/NASHNo drug interventionsNot AvailableNot Availablerecruiting
NCT05962099
Defining Circadian Metabolism in Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06275906
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.No drug interventionstreatmentNot Availablerecruiting
NCT05499949
The Franciscus Obesity NASH StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02649049
Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availablecompleted
NCT04146636
Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)No drug interventionsdiagnosticNot Availablecompleted
NCT04664036
Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes MellitusNo drug interventionsNot AvailableNot Availablerecruiting
NCT03585413
Impact of a Specific Micronutrient-probiotic-supplement on Fatty Liver of Patients After Mini-Gastric Bypass SurgeryNo drug interventionstreatment3completed
NCT04786418
Low-Calorie Diet in People With Prediabetes/Metabolic SyndromeNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05857319
Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06410924
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHNo drug interventionstreatment2recruiting
NCT05216796
Healthy Liver - Healthy BrainNo drug interventionsbasic_scienceNot Availablerecruiting
NCT06445335
Prevalence of NAFLD in T2DM PatientsNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03254563
Copeptin and Nonalcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05500586
The Effects of Glucagon on Hepatic Metabolismbasic_science1 / 2recruiting
NCT06465186
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)treatment2recruiting
NCT03203486
Response of NAFLD Patients to Mediterranean DietNo drug interventionsotherNot Availablecompleted
NCT02658786
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06398522
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic SyndromeNo drug interventionstreatmentNot Availablecompleted
NCT05044130
Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLDNo drug interventionsbasic_scienceNot Availablecompleted
NCT05309057
Network Meta-analysis of Intermittent Fasting and Cardiometabolic RiskNo drug interventionsNot AvailableNot Availableunknown_status
NCT04036357
Liver Damage and Cardiometabolic Disorders in NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT04215926
NAFLD in HIV-infected PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04527965
Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 DiabetesNo drug interventionstreatmentNot Availablecompleted
NCT03744182
A Study of Multiple Doses of HM15211 in Obese Subjects With NAFLDtreatment1completed
NCT04263376
Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLDNo drug interventionsNot AvailableNot Availablecompleted
NCT05015491
Effects of Online App Weight Loss Programs on Liver Health in Obese AdultsNo drug interventionstreatmentNot Availablecompleted
NCT04925362
THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)No drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT03132662
Omega-3 vs Very Low Calorie Diet for Liver Size ReductionNo drug interventionstreatmentNot Availableunknown_status
NCT04308980
Safety and Tolerability of Novel Medical Nutrition Products for NAFLD TreatmentNo drug interventionstreatment2 / 3unknown_status
NCT06579729
Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver DiseaseNo drug interventionspreventionNot Availablecompleted
NCT02006329
Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and AcupunctureNo drug interventionstreatmentNot Availableunknown_status
NCT05979389
Bicalutamide Therapy in Young Women With NAFLD and PCOSother1recruiting
NCT02663544
The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)No drug interventionspreventionNot Availablecompleted
NCT05579444
Systems Biology of Gastrointestinal and Related DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT04938544
Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT MeasurementsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02842567
Hydroxytyrosol and Vitamin E in Pediatric NASHtreatment3completed
NCT03463967
Effects of Tomato Products in Children With NAFLDNo drug interventionstreatmentNot Availableunknown_status
NCT04463667
Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver DiseaseNo drug interventionsotherNot Availableactive_not_recruiting
NCT03047668
POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 DiabetesNo drug interventionstreatmentNot Availableunknown_status
NCT04845646
DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.treatment1completed
NCT03980912
Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver BiopsyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05477212
Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.No drug interventionssupportive_careNot Availablerecruiting
NCT04561895
Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03914495
The Role of Microbiome Reprogramming on Liver Fat AccumulationNo drug interventionsbasic_scienceNot Availableterminated
NCT03783195
Genetic-specific Effects of Fructose on Liver LipogenesisNo drug interventionsbasic_scienceNot Availablecompleted
NCT04493814
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04235855
EUS Guided Liver Biopsy - Will it Give Better Yield, More Tissue With Less Complication?No drug interventionsdiagnosticNot Availablecompleted
NCT03371355
Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver DiseaseNo drug interventionstreatment2completed
NCT03145350
The Effect of a High-fat vs. High-sugar Diet on Liver Fat Accumulation and MetabolismNo drug interventionsbasic_scienceNot Availablecompleted
NCT04220450
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT06009250
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in AssiutNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05842850
Non-alcoholic Fatty Liver Disease in Low Birth Weight IndividualsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03639623
Safety, Tolerability and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With NAFLDtreatment2completed
NCT04576923
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver DiseaseNo drug interventionsdiagnosticNot Availableterminated
NCT05035043
Economic Burden of NAFLDNo drug interventionsotherNot Availableactive_not_recruiting
NCT04634643
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)No drug interventionsNot AvailableNot Availablerecruiting
NCT02609243
Diabetes Nutrition Algorithm - PrediabetesNo drug interventionspreventionNot Availableunknown_status
NCT04653103
NASH in Subjects With Different Classes of ObesityNo drug interventionsNot AvailableNot Availableunknown_status
NCT05424003
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplantprevention2recruiting
NCT04702490
Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASHtreatment2unknown_status
NCT06341790
Effect of Consumption of Millet Diet in Patients With NAFLDNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05378321
Prevalence of NAFLD in ACS PatientsNo drug interventionsscreeningNot Availablerecruiting
NCT05643521
The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese IndividualsNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT05479721
LITMUS Imaging StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04774302
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLDNo drug interventionsNot AvailableNot Availablerecruiting
NCT06130202
Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02828579
The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT02564679
Sleeve Gastrectomy in Adolescents With Complicated Morbid Obesity and NAFLDNo drug interventionstreatmentNot Availablecompleted
NCT01936779
Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in HumansNo drug interventionsbasic_scienceNot Availablecompleted